Follow The Filings

SNWV Sanuwave Health Inc.

Health Care, filed as SANUWAVE HEALTH INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.3%
  • $3.1M
  • 1 reduce

In 2026 Q2 James Silverman trimmed Sanuwave Health.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (James Silverman, Opaleye Management). Not free-float ownership.

  1. James Silverman Reduce 0.28%

Who owns SNWV

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management 0.28%, was 2.2% Reduce −68.8% 306,140 $3.1M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SNWV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SNWV insider trades
  • None no insider bought on the open market
  • $7.2M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Opaleye Management Inc. 10% owner
    Sale
    $574K 35,581 shares at $16.14 88% of stake
    Traded Apr 30–May 1 Filed May 4
    ↗
  2. Opaleye Management Inc. 10% owner
    Sale
    $1.3M 70,648 shares at $18.05 92% of stake
    Traded Apr 28–29 Filed Apr 30
    ↗
  3. Opaleye Management Inc. 10% owner
    Sale
    $337K 16,469 shares at $20.46 1.7% of stake
    Traded Apr 17–21 Filed Apr 21
    ↗
  4. Morgan C. Frank 10% owner, +4 joint filers
    Sale
    $559K 20,000 shares at $27.95 24% of stake
    Traded Dec 11–12 Filed Dec 15, 2025
    ↗
  5. Morgan C. Frank 10% owner, +4 joint filers
    Sale
    $4.5M 144,810 shares at $30.73
    Traded Dec 8–10 Filed Dec 11, 2025
    ↗
  6. Opaleye Management Inc. 10% owner
    Buy
    $38K 1,267 shares at $30.28 +0.1% to stake
    Traded Oct 6, 2025 Filed Oct 9, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 1.01,9.01 Filing Doc
8-K 3.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 4.02 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $19.26M $32.33M —
Gross profit $14.36M $24.55M $33.97M
Gross margin * 74.6% 75.9% —
Net income -$25.81M -$31.37M $11.81M
Net margin * -134.0% -97.0% —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $9.78M $18.4M $24.63M
Total non-current assets $12.63M $11.72M $12.72M
Total assets $22.42M $30.12M $37.34M
Total current liabilities $64.76M $42.34M $50.78M
Total non-current liabilities $0.839M $0.491M $17.88M
Total equity -$43.18M -$12.72M -$20.81M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$4.54M $2.46M $3.88M
Cash from investing $0.021M -$0.49M $3.43M
Cash from financing $5.21M $6.35M -$5.59M
Net change in cash $0.644M $8.44M $1.72M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.